Table 3 Dosimetric results
Dosimetric results | Median (range) |
|---|---|
Whole-prostate Treatment | n = 19 |
PTV volume (cm3) | 48 (16–131) |
PTV D98 (Gy) | 30.4 (8.7–36) |
PTV D95 (Gy) | 32.5 (13–36.5) |
PTV D50 (Gy) | 38.3 (35.2–40.2) |
PTV D2 (Gy) | 42.9 (39.3–46.9) |
CTV volume (cm3) | 29.5 (6–87.2) |
CTV D98 (Gy) | 35.8 (11.1–37,7) |
CTV D95 (Gy) | 36.3 (15.6–38.3) |
CTV D50 (Gy) | 38.8 (36.2–41) |
CTV D2 (Gy) | 42.2 (39.38–47.27) |
Hemi-prostate Treatment | n = 1 |
PTV volume (cm3) | 34.1 |
PTV D98 (Gy) | 14.83 |
PTV D95 (Gy) | 22.5 |
PTV D50 (Gy) | 39.67 |
PTV D2 (Gy) | 43.79 |
CTV volume (cm3) | 22.8 |
CTV D98 (Gy) | 21 |
CTV D95 (Gy) | 27.78 |
CTV D50 (Gy) | 40.41 |
CTV D2 (Gy) | 43.97 |
Focal treatment | n = 3 |
GTV volume (cm3) | 3.7 (0.6–6.9) |
GTV D98 (Gy) | 37.6 (37.58–37.71) |
GTV D95 (Gy) | 38.1 (37.99–38.16) |
GTV D50 (Gy) | 39.77 (39.32–40.23) |
GTV D2 (Gy) | 41.2 (41.19–41.22) |
Organ-at-risk | n = 23 |
Dmax rectum (Gy) | 34.8 (6.8–42.26) |
D2cc rectum | 23.83 (4–36.3) |
V12 rectum (cm3) | 8.2 (0–44.2) |
V27 rectum (cm3) | 1.3 (0–14.7) |
Dmax bladder (Gy) | 36.2 (15.9–41.9) |
D5cc bladder (Gy) | 25.3 (6.7–37.4) |
V12 bladder (cm3) | 16 (0.2–108) |
V27 bladder (cm3) | 3.2 (0–26.8) |